75 related articles for article (PubMed ID: 19731877)
21. Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter study.
Cazzaniga ME; Dogliotti L; Cascinu S; Barni S; Labianca R; Chiara S; Conte PF; Gasparini G; Pasetto L; Torri V
Oncology; 2006; 71(5-6):374-81. PubMed ID: 17785994
[TBL] [Abstract][Full Text] [Related]
22. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
[TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapy of bone metastases in breast cancer patients.
Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M
Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness and cost of bisphosphonate therapy in tumor bone disease.
Body JJ
Cancer; 2003 Feb; 97(3 Suppl):859-65. PubMed ID: 12548587
[TBL] [Abstract][Full Text] [Related]
25. [The role of adjuvant clodronate therapy for prevention of bone metastasis in breast cancer].
Horváth Z
Magy Onkol; 2002; 46(4):361-4. PubMed ID: 12563361
[TBL] [Abstract][Full Text] [Related]
26. Do physicians follow systemic treatment and funding policy guidelines?
Clemons M; Enright K; Cesta A; Charbonneau F; Chow E; Warr D; Kee-Cresswell D; Chang J; Yogendran G; Trudeau M; De Angelis C; Cottrell W; Dranitsaris G
Can J Clin Pharmacol; 2004; 11(1):e168-78. PubMed ID: 15300959
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer: bisphosphonate therapy for metastatic bone disease.
Body JJ
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6258s-6263s. PubMed ID: 17062710
[TBL] [Abstract][Full Text] [Related]
28. Patterns of bisphosphonate use in the United States in the treatment of metastatic bone disease.
Mortimer JE; Schulman K; Kohles JD
Clin Breast Cancer; 2007 Aug; 7(9):682-9. PubMed ID: 17919348
[TBL] [Abstract][Full Text] [Related]
29. [The current state of the evidence of malignant tumors of the eye and its adnexa (dg. C69) in the Slovak Republic and in the Czech Republic].
Furdová A; Oláh Z; Svetlošáková Z; Kusenda P
Cesk Slov Oftalmol; 2012 Nov; 68(5):195-201. PubMed ID: 23461371
[TBL] [Abstract][Full Text] [Related]
30. Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients.
Harries M; Taylor A; Holmberg L; Agbaje O; Garmo H; Kabilan S; Purushotham A
Cancer Epidemiol; 2014 Aug; 38(4):427-34. PubMed ID: 24923857
[TBL] [Abstract][Full Text] [Related]
31. Bisphosphonates for bone metastatic disease from breast cancer: clinical practice in the Czech Republic.
Vokata V; Odrazka K; Kubena A; Vlcek J
Clin Exp Metastasis; 2008; 25(4):371-6. PubMed ID: 17952615
[TBL] [Abstract][Full Text] [Related]
32. Long-term trends in the development of the epidemiology of breast cancer in the Slovak and Czech Republic with reference to applied screening and international comparisons.
Ondrusova M; Muzik J; Durdik S; Ondrus D
Neoplasma; 2012; 59(1):70-8. PubMed ID: 22103899
[TBL] [Abstract][Full Text] [Related]
33. Incidence of bone metastases in breast cancer patients in the United Kingdom: results of a multi-database linkage study using the general practice research database.
Hagberg KW; Taylor A; Hernandez RK; Jick S
Cancer Epidemiol; 2013 Jun; 37(3):240-6. PubMed ID: 23416031
[TBL] [Abstract][Full Text] [Related]
34. [Knowledge about cervical cancer among respondents in Slovakia and the Czech Republic - Aurora Project].
Švihrová V; Jílková E; Szabóová V; Baška T; Danko J; Hudečková H
Ceska Gynekol; 2015 Jun; 80(3):181-8. PubMed ID: 26087212
[TBL] [Abstract][Full Text] [Related]
35. Statistical modelling and prediction of lung cancer mortality in the Czech and Slovak Republics, 1960-1999.
Reissigovä J; Luostarinen T; Hakulinen T; Kubík A
Int J Epidemiol; 1994 Aug; 23(4):665-72. PubMed ID: 8002178
[TBL] [Abstract][Full Text] [Related]
36. [The incidence of tularemia in Slovakia in 1997-2008].
Gurycová D; Tináková K; Výrosteková V; Gacíková E
Epidemiol Mikrobiol Imunol; 2010 Feb; 59(1):39-44. PubMed ID: 21110446
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer bone metastases: an epidemiologic study in selected radiation departments.
Runco R; Laganà S; Marino G; Di Grazia A; Marino L; Umina V; Girlando A; Ricottone N; D'Agostino A; Marletta F; Tamburo M; Corsaro G; Rallo F; Santacaterina A; Acquaviva G; Crispi M; Palazzolo C; Platania A; Spatola C; Privitera G; Frosina P; Garufi G; Bonanno S; Rosso A; Barone V; Corallo A; Sansotta G; Delia P; Donato V; Lopes S; Pisana M; Borzì F; Iatì G; Potami A; Messina G; Parisi S; Frosina L; Marletta D; De Renzis C; Pontoriero A; Pergolizzi S
Tumori; 2014; 100(1):38-41. PubMed ID: 24675489
[TBL] [Abstract][Full Text] [Related]
38. Occupational diseases in the automotive industry from medical and geographic viewpoints - comparison between the Czech Republic and the Slovak Republic.
Jarolímek J; Legáth Ľ; Urban P
Cent Eur J Public Health; 2019 Dec; 27(4):296-304. PubMed ID: 31951689
[TBL] [Abstract][Full Text] [Related]
39. The CINP antidepressant task force report: comment concerning the Czech and Slovak republics.
Cesková E; Vavrusová L
Int J Neuropsychopharmacol; 2008 Nov; 11(7):1031-3. PubMed ID: 18570705
[No Abstract] [Full Text] [Related]
40. [Estimating the prevalence of potential drug interactions in patients treated with 5 and more drugs in the Czech Republic and Slovac Repuplic].
Češka R; Tkáč I
Vnitr Lek; 2016; 62(7-8):514-20. PubMed ID: 27627072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
